The Clinical and Experimental Use of Monoclonal Antibodies to the IL-2 Receptor
- 1 January 1995
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxisThe Lancet, 1995
- Humanization of mouse anti-human IL-2 receptor antibody B-B10Protein Engineering, Design and Selection, 1994
- MONOCLONAL ANTIBODIES IN PROPHYLACTIC IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION A RANDOMIZED CONTROLLED TRIAL COMPARING OKT3 AND ANTI-IL-2 RECEPTOR MONOCLONAL ANTIBODY LO-TACT-1Transplantation, 1993
- Disruption of the murine IL-4 gene blocks Th2 cytokine responsesNature, 1993
- Expression of the interleukin-2 receptor on human fibroblasts and its biological significanceInternational Immunology, 1992
- Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signallingNature, 1991
- Cytokines in T-cell developmentImmunology Today, 1991
- Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal AllograftsNew England Journal of Medicine, 1990
- ANTI-INTERLEUKIN 2 RECEPTOR MONOCLONAL ANTIBODY IN THE TREATMENT OF ONGOING ACUTE REJECTION EPISODES OF HUMAN KIDNEY GRAFT-A PILOT STUDYTransplantation, 1989
- Is immunological tolerance (non-responsiveness) a consequence of interleukin 2 deficit during the recognition of antigen?Immunology Today, 1984